Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2022

Conditions
Liver Disease
Interventions
GENETIC

genotyping and/or sequencing

genotyping and/or sequencing DNA for IL28

Trial Locations (1)

71013

"IRCCS Casa Sollievo della Sofferenza", San Giovanni Rotondo

All Listed Sponsors
collaborator

INMI L Spallanzani IRCCS Roma

UNKNOWN

collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

collaborator

Azienda Ospedaliera San Camillo Forlanini

OTHER

collaborator

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

collaborator

Azienda ospedaliera Garibaldi Nesinma Catania

UNKNOWN

collaborator

Azienda Ospedaliero-Universitaria Careggi

OTHER

collaborator

University of Milan

OTHER

collaborator

Catholic University, Italy

OTHER

collaborator

Ospedale Francesco Ferrari

OTHER

collaborator

Ospedale di Canosa di Puglia

UNKNOWN

collaborator

Ospedale di Venosa

UNKNOWN

collaborator

Clinica Santa Rita Bari

UNKNOWN

collaborator

Ospedale SS. Annunziata, Taranto

UNKNOWN

collaborator

Ospedali Riuniti di Foggia

OTHER

lead

Casa Sollievo della Sofferenza IRCCS

OTHER

NCT01437969 - Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment. | Biotech Hunter | Biotech Hunter